MENU
+Compare
RVNC
Stock ticker: NASDAQ
AS OF
Dec 18, 11:44 AM (EDT)
Price
$3.07
Change
-$0.00 (-0.00%)
Capitalization
320.48M

RVNC Revance Therapeutics Forecast, Technical & Fundamental Analysis

a developer of drugs

Industry Biotechnology
RVNC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for RVNC with price predictions
Dec 17, 2024

RVNC's Indicator enters downward trend

The Aroon Indicator for RVNC entered a downward trend on December 17, 2024. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 241 similar instances where the Aroon Indicator formed such a pattern. In of the 241 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 06, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on RVNC as a result. In of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for RVNC turned negative on December 10, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RVNC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where RVNC's RSI Oscillator exited the oversold zone, of 42 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RVNC advanced for three days, in of 266 cases, the price rose further within the following month. The odds of a continued upward trend are .

RVNC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. RVNC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (14.664). P/E Ratio (0.000) is within average values for comparable stocks, (87.689). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.783). RVNC has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (1.156) is also within normal values, averaging (260.687).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RVNC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
RVNC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

RVNC is expected to report earnings to fall 44.30% to -20 cents per share on March 04

Revance Therapeutics RVNC Stock Earnings Reports
Q4'24
Est.
$-0.21
Q3'24
Missed
by $0.10
Q2'24
Est.
$-0.36
Q1'24
Missed
by $0.03
Q4'23
Beat
by $0.03
The last earnings report on November 07 showed earnings per share of -37 cents, missing the estimate of -27 cents. With 514.00K shares outstanding, the current market capitalization sits at 320.48M.
A.I. Advisor
published General Information

General Information

a developer of drugs

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
1222 Demonbreun Street
Phone
+1 615 724-7755
Employees
597
Web
https://www.revance.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
USAGX19.96N/A
N/A
Victory Precious Metals and Minerals
ALCBX12.44N/A
N/A
ALPS/Smith Balanced Opportunity C
GTCEX27.95-0.09
-0.32%
Glenmede Strategic Equity
HHHCX16.95-0.08
-0.47%
Hartford Schroders Emerging Mkts Eq C
VSMVX408.77-5.89
-1.42%
Vanguard S&P Small-Cap 600 Val Idx Instl

RVNC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RVNC has been loosely correlated with AXON. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if RVNC jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVNC
1D Price
Change %
RVNC100%
-0.65%
AXON - RVNC
39%
Loosely correlated
-2.09%
HRMY - RVNC
39%
Loosely correlated
+1.72%
GOSS - RVNC
35%
Loosely correlated
+1.71%
ARRY - RVNC
34%
Loosely correlated
+6.01%
AVTE - RVNC
33%
Loosely correlated
N/A
More